Anchiano Therapeutics Ltd. ADR (ANCN) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Thu October 8th, 2020

- 16:00
  RatingAnalysisAll You Need to Know About Anchiano Therapeutics Ltd. Sponsored ADR (ANCN) Rating Upgrade to BuyZacks

Tue May 26th, 2020

- 12:00
  Press ReleasesAnchiano Appoints Stan Polovets as Chairman of the BoardBenzinga

SPY$328.22-3%

QQQ$273-3.4%

DOW$45.15-3%

ETSY$138-5.3%

MA$292.5-7.8%

OPK$4.13-0.24%

PG$138.25-2.9%

XOM$32-2.5%

SPY$328.22-3%

QQQ$273-3.4%

DOW$45.15-3%

ETSY$138-5.3%

MA$292.5-7.8%

OPK$4.13-0.24%

PG$138.25-2.9%

XOM$32-2.5%

About Developer Contact